ea0047oc48 | Innovative Theranostics | Theranostics2016
Velikyan Irina
, Wennborg Anders
, Frldwisch Joachim
, Olofsson Helena
, Sandberg Dan
, Lubberink Mark
, Sandstrom Mattias
, Lindman Henrik
, Carlsson Jorgen
, Sorensen Jens
The currently best known example of a commercialized theranostics is the combination of HercepTest and Herceptin wherein the former is used for HER2 expression assessment and selection of patients that might benefit from the treatment with the latter. However, HercepTest requires biopsy which is an invasive procedure, not sufficiently accurate, and very difficult to perform on several lesions and repeatedly in order to monitor the treatment response. While positron emission to...